These include new engineering thermoplastic material solutions with improved haemo-compatibility for use in blood contact applications and devices that require low protein binding, e.g. those found in several diagnostic or biopharmaceutical applications.
Estech’s single-use ClearView MV Atrial Depressor utilises GE’s advanced haemo-compatible Lexan for device reliability and biocompatibility in minimally invasive mitral valve repair and replacement procedures. Among other customers’ devices are the Megadyne Electrosurgical E-Z Pen, GE Healthcare’s Aisys Carestation anaesthesia delivery system and others.
‘We have continued building capabilities to help our customers turn their innovative designs into application successes,’ explained Clare Frissora, Marketing Director, Healthcare, GE Plastics. With continuing investment in new technical capabilities and materials technologies, developments in the last two years include higher flow and release autoclavable Lexan HPX resins; higher heat autoclavable Lexan 4504 resin; GE’s lipid resistant Lexan HPS7 resin, and Noryl HNA resins to meet greater exposure to certain chemicals and higher heat autoclave temperatures.
Hall 10, booth A56